The long-term goal of this grant is to deduce general rules for how protein kinase signal transduction pathways maintain fidelity in signaling. Research over the past 10 years in this laboratory and other laboratories indicates that specificity in signaling occurs through a rapidly reversible regulated assembly of specific protein complexes in subcompartinents of the cell. The hypothesis guiding this study is that domains on signaling proteins mediate assembly into specific complexes via interaction with relatively short sequence motifs on target proteins. Additional fidelity is derived by the specificity of protein kinase catalytic domains for unique substrate motifs. Thus, subtle differences in kinases either within motifs or in residues that form the pockets of domains can explain their abilities to assemble into distinct complexes and phosphorylate distinct proteins in vivo. We have developed a peptide library screening approach that allows one to rapidly deduce optimal motifs for binding to protein interaction domains or to deduce optimal sequences for phosphorylation by protein kinases.
The aims of the research are. 1) To use this approach to deduce optimal binding motifs for protein binding domains and protein kinases implicated in cell growth and cell survival pathways; 2) To isolate novel domains that bind phosphoSer (or phosphoThr) sites phosphorylated by specific protein kinases using a novel approach that we have developed; 3) To apply a new peptide library approach for determining substrates of proteases involved in cell growth and survival pathways; 4) To ascertain the structural basis for sequence-specific binding to the domains explored in aims 1 and 2; 5) To develop a web-based program that utilizes the information from the peptide library scans to predict binding sites and phosphorylation sites on proteins based on primary sequences.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM056203-06
Application #
6519828
Study Section
Physical Biochemistry Study Section (PB)
Program Officer
Jones, Warren
Project Start
1997-07-01
Project End
2005-06-30
Budget Start
2002-07-01
Budget End
2003-06-30
Support Year
6
Fiscal Year
2002
Total Cost
$340,000
Indirect Cost
Name
Beth Israel Deaconess Medical Center
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02215
Wu, Ning; Zheng, Bin; Shaywitz, Adam et al. (2013) AMPK-dependent degradation of TXNIP upon energy stress leads to enhanced glucose uptake via GLUT1. Mol Cell 49:1167-75
Baker, Rachael; Lewis, Steven M; Sasaki, Atsuo T et al. (2013) Site-specific monoubiquitination activates Ras by impeding GTPase-activating protein function. Nat Struct Mol Biol 20:46-52
Israelsen, William J; Dayton, Talya L; Davidson, Shawn M et al. (2013) PKM2 isoform-specific deletion reveals a differential requirement for pyruvate kinase in tumor cells. Cell 155:397-409
Carracedo, Arkaitz; Cantley, Lewis C; Pandolfi, Pier Paolo (2013) Cancer metabolism: fatty acid oxidation in the limelight. Nat Rev Cancer 13:227-32
Chen, Sen; Jiang, Xinnong; Gewinner, Christina A et al. (2013) Tyrosine kinase BMX phosphorylates phosphotyrosine-primed motif mediating the activation of multiple receptor tyrosine kinases. Sci Signal 6:ra40
Son, Jaekyoung; Lyssiotis, Costas A; Ying, Haoqiang et al. (2013) Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway. Nature 496:101-5
Yuan, Ping; Ito, Koichi; Perez-Lorenzo, Rolando et al. (2013) Phenformin enhances the therapeutic benefit of BRAF(V600E) inhibition in melanoma. Proc Natl Acad Sci U S A 110:18226-31
Emerling, Brooke M; Benes, Cyril H; Poulogiannis, George et al. (2013) Identification of CDCP1 as a hypoxia-inducible factor 2ýý (HIF-2ýý) target gene that is associated with survival in clear cell renal cell carcinoma patients. Proc Natl Acad Sci U S A 110:3483-8
Shen, Che-Hung; Yuan, Ping; Perez-Lorenzo, Rolando et al. (2013) Phosphorylation of BRAF by AMPK impairs BRAF-KSR1 association and cell proliferation. Mol Cell 52:161-72
Fendt, Sarah-Maria; Bell, Eric L; Keibler, Mark A et al. (2013) Metformin decreases glucose oxidation and increases the dependency of prostate cancer cells on reductive glutamine metabolism. Cancer Res 73:4429-38

Showing the most recent 10 out of 102 publications